NCT00320957View on ClinicalTrials.gov

Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Zhong-Shan Hospital

PHASE3CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

December 31, 2006

Conditions
GlaucomasPterygium
Interventions
DEVICE

OculusGen Biodegradable Collagen Matrix Implant

Trial Locations (1)

200032

Zhongshan Hospital Fudan University, Shanghai

All Listed Sponsors
lead

Pro Top & Mediking Company Limited

INDUSTRY

NCT00320957 - Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Zhong-Shan Hospital | Biotech Hunter | Biotech Hunter